Clinical Trial

CS-206 in Patients With Sickle Cell Disease

Name: CS-206 in Patients With Sickle Cell Disease — clinical trial record (NCT07000318)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-206 injection in treating sickle cell disease.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-30.

Trial Details

NCT Number	NCT07000318
Lead Sponsor	Children's Hospital of Fudan University
Conditions	Sickle Cell Disease
Enrollment	5 participants
Start Date	2026-09-30
Primary Completion	2028-12-30 (estimated)
Study Completion	2029-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-15